Magnachip Semiconductor Corporation (NYSE: MX) ("Magnachip" or the "Company") today announced financial results for the first ...

Prior art patents and publications have long been the primary source for anticipation and obviousness assertions by defendants in IP ...

Last week, readers were most interested in a story about Castle Biosciences' buy of Previse and its plans to expand its gastrointestinal diagnostic test offerings.